quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:01:53·1d
SECFiling
AN2 Therapeutics Inc. logo

SEC Form DEF 14A filed by AN2 Therapeutics Inc.

ANTX· AN2 Therapeutics Inc.
Health Care
Original source

Companies

  • ANTX
    AN2 Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Aug 9UpdateEvercore ISI-
  • Aug 9UpdateLeerink Partners$1.00
  • Jul 3UpdateLeerink Partners$5.00
  • Apr 2UpdateJMP Securities$6.00
  • Feb 13UpdateLeerink Partners$7.00
  • Feb 12UpdateEvercore ISI$7.00

Related

  • SEC1d
    SEC Form DEFA14A filed by AN2 Therapeutics Inc.
  • SEC3d
    SEC Form EFFECT filed by AN2 Therapeutics Inc.
  • SEC3d
    SEC Form 424B3 filed by AN2 Therapeutics Inc.
  • SEC3d
    SEC Form 424B5 filed by AN2 Therapeutics Inc.
  • INSIDER13d
    SEC Form 4 filed by Aziz Kabeer
  • INSIDER13d
    SEC Form 4 filed by Marks Gilbert Lynn
  • INSIDER13d
    SEC Form 4 filed by Martin Patricia A.
  • SEC14d
    SEC Form S-3 filed by AN2 Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022